ctrl K

Price Alert

Mineralys Therapeutics In... (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

14.66

-0.68 (-4.43%)

At close: Aug 19, 2025, 11:51 AM

Mineralys Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	114.09M	49.3M	87.7M	10.61M
Short-Term Investments	84.1M	187.26M	22.41M	n/a
Long-Term Investments	n/a	2.48M	n/a	n/a
Other Long-Term Assets	499K	51K	4.33M	3K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	7.16M	12.54M	2.7M	50K
Total Current Assets	205.35M	249.1M	112.81M	11.12M
Property-Plant & Equipment	53K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	552K	2.53M	4.33M	3K
Total Assets	205.9M	251.64M	114.44M	11.13M
Account Payables	479K	601K	1.91M	763K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	1.6M	n/a	n/a
Total Current Liabilities	14.65M	10.48M	8.07M	5.05M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	158.64M	29M
Total Long-Term Liabilities	n/a	n/a	158.64M	29M
Total Liabilities	14.65M	10.48M	166.71M	34.05M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	5K	4K	1K	1K
Retained Earnings	-302.52M	-124.71M	-52.81M	-23.01M
Comprehensive Income	n/a	-251.64M	-158.64M	n/a
Shareholders Equity	191.26M	241.15M	-52.27M	-22.93M
Total Investments	84.1M	189.75M	22.41M	n/a